A*STAR SBIC spin-off Respiree

Sensor predict clinical respiratory deterioration

Respiree, a SBIC spin-off together with National University Hospital and NUS Yong Loo Lin School of Medicine, is developing a sensor to help health workers monitor COVID-19 patients.

SBIC Sarah Luo

Do our brains shape our diets?

Senior Research Fellow of SBIC's Brain Plasticity Group, Dr Sarah Luo shares about her work in an interview for Singapore Today on radio channel CNA938.


New target in liver cancer treatment revealed

Researchers at SBIC have identified two metabolic enzymes as possible drug targets to inhibit cancer cell growth in hepatocellular carcinoma (HCC).

SBIC Metabolic Imaging MRI GUSTO

New perspectives in treatment of metabolic diseases

Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are powerful tools for for assessing body composition and measuring metabolic activity.

Image carousel SBIC

Imaging today the medicine of tomorrow

In close partnership with both industry and clinicians, researchers at the Singapore Bioimaging Consortium are changing the way we see the human body to improve health and well-being.

Singapore Bioimaging Consortium(SBIC)

Singapore Bioimaging Consortium (SBIC) is one of the 10 research institutes of the Biomedical Research Council under the Agency for Science, Technology and Research (A*STAR) in Singapore. 

Located in Singapore’s premier international research and development hub for biomedical sciences, at the heart of Biopolis, the centre occupies 5 levels of the Helios building and is staffed by 130 multi-disciplinary imaging experts, including biologists, chemists, physicists, engineers and clinicians. SBIC is a national bioimaging hub for biomedical research. Equipped with state-of-the-art instruments, we lead strategic partnerships for technology developments.

Together with our academic, clinical and industrial partners, we develop bioimaging applications, as well as promote the co-ordination of national bioimaging efforts and initiatives.